# Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression.

> **NCT03265808** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ihsan M Salloum, MD, MPH** · enrollment: 31 (actual)

## Conditions studied

- Major Depressive Disorder
- Alcohol Use Disorder

## Interventions

- **DRUG:** allogeneic human mesenchymal stem cells (allo-hMSCs)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03265808
- **Lead sponsor:** Ihsan M Salloum, MD, MPH
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-18
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2026-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03265808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03265808, "Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03265808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*